Skip to main content
Watch Insiders

Corporate insider profile

David R Epstein Insider Trades

Latest reported as Corporate insider of AgomAb Therapeutics NV (AGMB).

Purchase filings
4
Reported companies
2
Net open-market value
$250,867
Latest transaction
Nov 5, 2026

Affiliated corporations

Reported company relationships

AGMBLatest reported

AgomAb Therapeutics NV

Corporate insider

TEMPrior filing

Tempus AI, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 5, 2026AgomAb Therapeutics NV (AGMB)Corporate insiderOpen Market Purchase15,000$6.90$103,500
Nov 2, 2026Tempus AI, Inc. (TEM)DirectorSale370$74.29$27,487
Oct 21, 2026AgomAb Therapeutics NV (AGMB)Corporate insiderOpen Market Purchase10,000$8.88$88,800
Oct 8, 2026AgomAb Therapeutics NV (AGMB)Corporate insiderOpen Market Purchase5,000$8.90$44,500
Oct 6, 2026AgomAb Therapeutics NV (AGMB)Corporate insiderOpen Market Purchase10,000$8.64$86,350
Sep 1, 2026Tempus AI, Inc. (TEM)DirectorSale250$65.55$16,388
Aug 3, 2026Tempus AI, Inc. (TEM)DirectorSale370$43.40$16,058
Jun 1, 2026Tempus AI, Inc. (TEM)DirectorSale250$49.40$12,350